A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19
Clinical trial NCT04605926 · WITHDRAWN
Trial details
- NCT number
- NCT04605926
- Sponsor
- Biocon Limited
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2021-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.